Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2009
Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction
Michael Stahl, Martin K Walz, Martin Stuschke, et al.
BMC Cancer
|
July 23, 2024
Subgroup analyses from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial
Meinolf Karthaus, Volker Heinemann, Jorge Riera-Knorrenschild, et al.
Neuroimage
|
September 21, 2016
The neurogenesis of P1 and N1: A concurrent EEG/LFP study
Michael Bruyns-Haylett, Jingjing Luo, Aneurin J Kennerley, et al.
International Journal of Cancer
|
February 9, 2023
First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Final results of the NEPTUN study
Tobias Dechow, Jorge Riera-Knorrenschild, Björn Hackanson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2015
Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie
Sylvie Lorenzen, Jorge Riera Knorrenschild, Georg-Martin Haag, et al.
BMC Cancer
|
June 19, 2023
Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415)
Sylvie Lorenzen, Alix Schwarz, Claudia Pauligk, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 15, 2021
Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung)
Martin Sebastian, Andreas Gröschel, Sylvia Gütz, et al.
BMC Cancer
|
June 4, 2020
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)
Joseph Tintelnot, Eray Goekkurt, Mascha Binder, et al.
International Journal of Cancer
|
March 6, 2024
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy
Michael Masetti, Salah-Eddin Al-Batran, Thorsten O Goetze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2021
HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study
Ivonne Haffner, Katrin Schierle, Elba Raimúndez, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2009
Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction
Michael Stahl, Martin K Walz, Martin Stuschke, et al.
BMC Cancer
|
July 23, 2024
Subgroup analyses from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial
Meinolf Karthaus, Volker Heinemann, Jorge Riera-Knorrenschild, et al.
Neuroimage
|
September 21, 2016
The neurogenesis of P1 and N1: A concurrent EEG/LFP study
Michael Bruyns-Haylett, Jingjing Luo, Aneurin J Kennerley, et al.
International Journal of Cancer
|
February 9, 2023
First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Final results of the NEPTUN study
Tobias Dechow, Jorge Riera-Knorrenschild, Björn Hackanson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2015
Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie
Sylvie Lorenzen, Jorge Riera Knorrenschild, Georg-Martin Haag, et al.
BMC Cancer
|
June 19, 2023
Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415)
Sylvie Lorenzen, Alix Schwarz, Claudia Pauligk, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 15, 2021
Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung)
Martin Sebastian, Andreas Gröschel, Sylvia Gütz, et al.
BMC Cancer
|
June 4, 2020
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)
Joseph Tintelnot, Eray Goekkurt, Mascha Binder, et al.
International Journal of Cancer
|
March 6, 2024
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy
Michael Masetti, Salah-Eddin Al-Batran, Thorsten O Goetze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2021
HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study
Ivonne Haffner, Katrin Schierle, Elba Raimúndez, et al.
Page
of 8